Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | E2F5 |
| Upstream (Parents) |
|---|
| (<<) ESRP1 → E2F5 |
| (<<) SLC35F2 → E2F5 |
| (<<) DSCC1 → E2F5 |
| (<<) TAF1D → E2F5 |
| (<<) BZW2 → E2F5 |
| Downstream (Children) |
|---|
| E2F5 → LAPTM4B (>>) |
| E2F5 → RAD54B (>>) |
| E2F5 → DLC1 (>>) |
| E2F5 → BOP1 (>>) |
| E2F5 → ALDH1A2 (>>) |
| E2F5 → FES (>>) |
| E2F5 → PAQR5 (>>) |
| E2F5 → FAM86A (>>) |
| E2F5 → TSPAN7 (>>) |
| E2F5 → MRPS12 (>>) |
| E2F5 → DSCC1 (>>) |
| E2F5 → CBFA2T3 (>>) |
| E2F5 → PDP1 (>>) |
| E2F5 → PPFIA1 (>>) |
| E2F5 → RIPK2 (>>) |
| E2F5 → EIF2C2 (>>) |
| E2F5 → RRP9 (>>) |
| E2F5 → YAP1 (>>) |
| E2F5 → SETBP1 (>>) |
| E2F5 → SNX16 (>>) |
